| 118 |
Lead Discovery Center |
Genitourinary disease |
Antibody |
A Novel FGFR4 Antibody to Treat Cardiac Death in Chronic Kidney Disease (CKD)
|
| 117 |
Lead Discovery Center |
Cardiovascular disease |
Protein |
GRK5 - Crucial Regulator in Cardiac Hypertrophy
|
| 116 |
Lead Discovery Center |
Neurology |
Small molecule |
SPR-Inhibitors in the field of Neuropathic Pain with an upside In Inflammation/Autoimmune
|
| 115 |
Johns Hopkins University |
Musculoskeletal disease |
Small molecule |
Tonabersat as a Neuroprotective Compound for Amyotrophic Lateral Sclerosis
|
| 114 |
Johns Hopkins University |
Oncology |
Small molecule |
Enhancing Translation of LINE-1 Encoded ORF2p for Cancer Therapeutics
|
| 113 |
Johns Hopkins University |
Oncology |
Gene therapy |
Engineered Fibroblasts as Cell Therapy to Treat Cancer via Tumor Stroma Stabilization
|
| 112 |
Johns Hopkins University |
Immunology |
Cell therapy |
Engineered Tolerogenic Artificial Antigen-presenting Cells for Specific Expansion of Regulatory T Cells
|
| 111 |
Emory University |
Oncology |
Cell therapy |
Genetic Mutation in Immune Cells for Infectious Disease and Cancer Therapy
|
| 110 |
Emory University |
Oncology |
Small molecule |
Small Molecule Inhibitors of Mcl-1 as Anti-Cancer Agent
|
| 109 |
Emory University |
Oncology |
Small molecule |
Small Molecule for Treatment-Resistant Lung Cancer
|
| 108 |
Emory University |
Oncology |
Protein |
Photocaged Cytokines for Cancer Immunotherapy
|
| 107 |
Emory University |
Cardiovascular disease |
Nucleotide |
Use of miRNA-483 and its Target Genes in Treatment of Cardiovascular and Inflammatory Diseases
|
| 106 |
Duke University |
Ophthalmology |
Gene therapy |
Gene Therapy for Long-term Decrease of Intraocular Pressure
|
| 105 |
Cancer Research Horizons |
Oncology |
Antibody |
Arginase-2 (Arg2) Inhibitor
|
| 104 |
Cancer Research Horizons |
Oncology |
Peptide |
Novel Apelin Receptor Antagonist
|
| 103 |
City of Hope |
Oncology |
Antibody |
Engineered PSCA antibody for Targeted Radiotherapy
|
| 102 |
City of Hope |
Oncology |
Antibody |
Differentiated CD38-CD3 Bionic to Treat AML
|
| 101 |
City of Hope |
Oncology |
Antibody |
Targeting IL1RAP To Eradicate Leukemia Stem Cells (LSC) In Acute Myeloid Leukemia (AML)
|
| 100 |
City of Hope |
Oncology |
Cell therapy |
TAG72 CAR T Asset and Tethered IL-12 platform
|
| 99 |
City of Hope |
Oncology |
Peptide |
FabRack Universal CAR-T
|
